{"id":"F2013L02033","name":"Therapeutic Goods (Listing) Notice 2013 (No. 7)","slug":"therapeutic-goods-listing-notice-2013-no-7","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":128208,"registerId":"commonwealth-F2013L02033-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2013 (No. 7)","content":"Therapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2013 (No. 7)\n\nI, JOHN SKERRITT, National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:\n\n    preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘alanylglutamine’ as a therapeutically active ingredient, subject to the following condition:\n\n-   the preparations are for oral use only.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.\n\nDated this 22nd day of November 2013\n\n(Signed by)\n\nJohn Skerritt\n\nDelegate of the Minister for Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1574},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This is a targeted administrative notice performing exactly its intended function: temporarily listing a specific therapeutic ingredient pending formal regulatory amendment. It has not expanded beyond its original purpose."},"complexity_factors":["Single active ingredient specified (alanylglutamine)","Only one condition imposed (oral use only)","No nested definitions or complex conditional logic","Automatic cessation mechanism tied to future regulatory amendment"],"plain_english_summary":"This notice temporarily permits dietary supplements containing alanylglutamine to be sold in Australia as listed (non‑prescription) medicines by adding the ingredient to the ARTG as a permitted listed‑medicine ingredient. It’s limited to oral products and provides a legal bridge until the Therapeutic Goods Regulations are formally amended. Affects manufacturers/importers and consumers while the temporary pathway remains."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2013-no-7","history":"/api/acts/therapeutic-goods-listing-notice-2013-no-7/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2013-no-7/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2013-no-7/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2013-no-7/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2013-no-7/documents"}}